Antimicrobial Composition for Respiratory Pathogen Reduction

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need for effective therapeutic materials and methods to treat respiratory infections caused by viral and bacterial pathogens, particularly in situations where there are no approved treatments, such as for COVID-19 caused by SARS-CoV-2.

Innovation Solution

A composition with antimicrobial activity is disclosed, which includes a compound with the chemical formula [HxO(x-1)2]Zy, where x is an odd integer greater than or equal to 3, y is an integer between 1 and 20, and Z is a monoatomic or polyatomic ion. This composition is used to treat respiratory conditions and can be administered as a vaporized or atomized fluid to reduce microbial pathogen load in the respiratory system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antimicrobial treatments are used, then microbial pathogen load is reduced, but tissue damage or toxicity occurs

Engineering Contradiction:

Improveantimicrobial efficacyVSAvoidtissue damage

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of the antimicrobial agent by using a specific compound formula [HxO(x-1)2]Zy with controlled stoichiometry and selecting appropriate anions (sulfate, nitrate, phosphate, halides) to achieve effective pathogen reduction while maintaining tissue compatibility through optimized chemical composition

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention employs a composite chemical structure combining cationic hydronium cores with various anionic components to create a multifunctional antimicrobial agent that achieves both high efficacy against pathogens and reduced tissue toxicity through the synergistic interaction of its compositional elements

Inventive Principle:

Principle #40Composite materials

2Reliability

If approved treatments are used, then respiratory infection symptoms are treated, but no effective treatment exists for certain pathogens like SARS-CoV-2

Engineering Contradiction:

Improvetreatment efficacyVSAvoidapplicability to unapproved pathogens

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal antimicrobial composition with the formula [HxO(x-1)2]Zy that can treat multiple types of pathogens including bacteria, viruses (such as SARS-CoV-2), and fungi through a single versatile formulation, addressing the need for treatments against pathogens without approved specific therapies

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250073259A1Aqueous anti microbial composition useful as a therapeutic material

Publication Date: 2025.03.06 TYGRUS LLC

AI summary

A therapeutic material active against SARS-COV 2 and other microbial pathogens and method of administering the same.